Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Pathologie (Heidelberg, Germany)|October 24, 2023
Testing for deficient mismatch repair and microsatellite instability : A focused updateJosef Rüschoff, Hans-Ulrich Schildhaus, Jan Hendrik Rüschoff, et al.
Pathologie (Heidelberg, Germany)|August 7, 2023
[Testing deficient mismatch repair and microsatellite instability : A focused update. German version]Josef Rüschoff, Hans-Ulrich Schildhaus, Jan Hendrik Rüschoff, et al.
Scientific Reports|October 10, 2018
Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrenceHelen Pasternack, Jana Fassunke, Patrick Sven Plum, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 casesJerzy Lasota, Christopher L Corless, Michael C Heinrich, et al.
Scientific Reports|June 6, 2024
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design mattersMichaela A Ihle, Carina Heydt, Anne Maria Schultheis, et al.
JTO Clinical and Research Reports|March 12, 2026
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET InhibitionRichard Riedel, Lea Ruge, Malte Verheyen, et al.
Virchows Archiv : an International Journal of Pathology|September 9, 2017
EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trialJana Fassunke, Michaela Angelika Ihle, Dido Lenze, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 2020
Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrenceAsmae Gassa, Jana Fassunke, Sarah Schueten, et al.
Clinical Chemistry|January 12, 2017
Identification of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor gradingSimon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Pageof 17